Friday, May 31, 2024

Leading Change in Cancer Clinical Research, Because Our Patients Can’t Wait - Cancer Currents Blog

Having trouble viewing this email? View it as a Web page.
Latest from Cancer Currents
05/31/2024
Reshaping the cancer clinical trials infrastructure to overcome key bottlenecks will involve embracing technology and collaboration, and inviting innovation, explain NCI Director Dr. W. Kimryn Rathmell and NCI Special Advisor Dr. Shaalan Beg.

Read the Story

You are subscribed to the latest posts from Cancer Currents: An NCI Cancer Research Blog from the National Cancer Institute. Update your subscriptions.

Bookmark and Share

This email was sent to edwardlorilla1986.paxforex@blogger.com using GovDelivery Communications Cloud on behalf of: National Cancer Institute · BG 9609 MSC 9760 · 9609 Medical Center Drive · Bethesda, MD 20892 GovDelivery logo

No comments:

Post a Comment

Introducing pharmatech VC, PE research

Can VC opportunity funds stage a comeback?; PE healthcare specialists lead fundraising; Euro...